Base Year
Historical Year
Forecast Year
The global contraceptive drugs market size attained a value of USD 18.64 billion in 2023. The market is further expected to grow at a CAGR of 7% during the forecast period of 2024-2032 to attain a value of USD 34.33 billion by 2032. The growth of the market is driven by the increasing awareness and acceptance of contraceptive drugs.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
As governments are increasingly attempting to enhance the quality of life of their citizens, they are increasingly providing free and subsidised contraceptive drugs, thereby driving the growth of the market. Moreover, governments of low-and-middle-income companies are launching various favourable initiatives like advertisements to promote contraceptive drugs among their population.
For instance, in July 2019, the Health Ministry of India released about three commercials to promote oral contraceptives. In addition, various governments are selling contraceptive pills at pharmacy stores without doctor’s prescriptions, which is significantly contributing to the growth of the market.
The initiation of various family planning programmes and media campaigns to increase awareness regarding the importance and benefits of contraceptive drugs is augmenting the market growth. The redistribution of contraceptive services among health workers and pharmacy staff, among others, is increasing the accessibility of the underserved population of injectables and oral contractions. Hence, the increasing availability of diverse contraceptive drugs in developing countries is aiding the market growth. The development of new contraceptive technologies to boost the functionality and efficiency of contraceptive drugs is providing further impetus to the growth of the market.
Contraceptive drugs, variously known as birth control drugs, are medicines that prevent unwanted pregnancies by releasing hormones like oestrogen and progesterone. They thicken mucus around the cervix to prevent ovulation. Contraceptive drugs are convenient to use and lower the risk of various health-related issues like breast cancer and polycystic ovary syndrome (PCOS), among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major products of contraceptive drugs are:
The market can be broadly categorised on the basis of its age groups into:
Based on end-users, the market is divided into:
The EMR report looks into the regional markets of contraceptive drugs like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The development of innovative contraceptive drugs to minimise the side-effects like nausea and vomiting is propelling the market growth. With the increasing attempts to boost the benefits of contraceptive drugs, new modes for their administration to enhance patient experience is surging, which is aiding the market growth. Furthermore, the increasing research activities to develop advanced contraceptive drugs is expected to propel the market growth. The rising acceptance of innovative contraceptive drugs like once-a-month pills to prevent ovulation or implantation is significantly contributing to the growth of the industry.
The increasing focus to provide innovative solutions for shared reproductive burden among both males and females is anticipated to drive the growth of the market. This is also leading to the initiation of various clinical trials of contraceptive drugs that stop sperm production to prevent unplanned pregnancies. As conventional contraceptive drugs result in side effects like nausea, vomiting, and mood swings, among others, long-acting reversible contraceptives are being developed, which is anticipated to bolster the industry growth. Moreover, increasing research activities to develop oestrogen-free drugs to lower failure rates as compared to oestrogen-based contraception is predicted to propel the market growth.
The report presents a detailed analysis of the following key players in the global contraceptive drugs market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Route of Administration |
|
| Breakup by Therapy Type |
|
| Breakup by Age Group |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2023, the global contraceptive drugs market attained a value of nearly USD 18.64 billion.
The market is projected to grow at a CAGR of 7% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 34.33 billion by 2032.
The market is being aided by the increasing availability of free and subsidised contraceptive drugs, the initiation of various family planning programmes and media campaigns, and the development of new contraceptive technologies.
The industry is expected to be augmented by the development of advanced contraceptive drugs, the rising acceptance of innovative contraceptive drugs, and the increasing clinical trials of contraceptive drugs for men.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major products of contraceptive drugs in the industry are topical contraceptives, oral contraceptive pills, and injectable contraceptives.
The significant age groups in the market are 15-24 years, 25-34 years, 35-44 years, and above 44 years.
The various end-users of contraceptive drugs are homecare, hospitals, and clinics.
The major players in the industry are Allergan plc, Johnson & Johnson, Bayer AG, Piramal Healthcare, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Novartis AG, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share